Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor

Hormone Research

Volumn 50, Issue 4, 1998, Pages 226-231

  Chabot, Valdo ^a   De Keyzer, Yves ^b   Gebhard, Sandra ^a   Uské, Antoine ^a   Bischof Delaloye, Angelika ^a   Rey, François ^a   Dusmet, Michel ^a   Gomez, Fulgencio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

Author keywords

Bronchial carcinoid; CRH receptors; Ectopic Cushing's syndrome; Vasopressin receptors

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DEXAMETHASONE; SOMATOSTATIN RECEPTOR; VASOPRESSIN V3 RECEPTOR;

AGED; ARTICLE; CARCINOID; CASE REPORT; CATHETERIZATION; CAVERNOUS SINUS; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; CUSHING DISEASE; ECTOPIC HORMONE PRODUCTION; ENDOSCOPIC ECHOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NODULE; PRIORITY JOURNAL; RECEPTOR GENE; SCINTIGRAPHY;

EID: 0031774119     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023279     Document Type: Article

References (40)

1. Viaud FJ, Tabarin A, Corcuff JB, Laurent F, Bergé J, Trouette H, Trouillas J, Velly JF, Caillé JM, Roger P: Le syndrome de Cushing para-néoplasique: Approche diagnostique et thérapeutique. Rev Fr Endocrinol Clin Nutr Metab 1995;36:417-431.
2. Findling JW, Kehoe ME, Shaker JL, Raff H: Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: Early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab 1991;73:408-413.
3. Kreisberg R: Half a loaf. Clinical problem-solving. N Engl J Med 1994;330:1295-1299.
4. Tabarin A, Catargi B, Chanson P, Hieronimus S, Corcuff JB, Laurent F, Harter M, Drouillard J, Roger P: Pseudo-tumours of the thymus after correction of hypercortisolism in patients with ectopic ACTH syndrome: A report of five cases. Clin Endocrinol 1995;42:207-213.
5. de Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X: The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996;97:1311-1318.
6. Yanovski JA, Cutler GB, Chrousos GP, Nieman LK: Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993;269:2232-2238.
7. Torriani F, Uské A, Temler E, Rey F, Hurlimann J, Delaloye B, Gomez F: Pancreatic insuloma causing Cushing's syndrome. J Endocrinol Invest 1989;12:313-319.
8. Waeber G, Gomez F, Bishof-Delaloye A, Chaubert P, Francke ML, Haefliger JA, Scherrer U, Centeno G, Temler E, Nicod P: Insulinoma associated with a case of multiple endocrine neoplasia type I (MEN I): Functional somatostatin receptors and abnormal glucose-induced insulin secretion. Horm Res 1997;48:76-82.
9. Von Moll L, McEvan AJ, Shapiro B, Sisson JC, Gross MD, Lloyd R, Beals E, Beierwaltes WH, Thompson NW: Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med 1987;28:979-988.
10. Marini M, Rey F, Gomez F: Test à la corticolibérine ovine (oCRH): application clinique et valeurs de référence chez l'adulte jeune et la femme postménopausée. Schweiz Med Wochenschr 1991;121:653-659.
11. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed paraffin embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
12. Sternberg LA, Hardy PHJ, Cuculis J, Meyer HG: The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970;18:315-333.
13. Hsu SM, Raine L, Fanger H: A comparative study of the PAP method and avidin biotincomplex method for studying polypeptide hormones with radio-immunoassay antibodies. Am J Clin Pathol 1981;75:734-738.
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory, 1989.
16. Colby TV, Koss MN, Travis WD: Tumors of the Lower Respiratory Tract, ed 3. Washington, Armed Forced Institute of Pathology, 1995.
17. Jard S: Vasopressin receptors. Front Horm Res. Basel, Karger, vol 13, pp 89-104.
18. Leinung MC, Young WF Jr, Whitaker MD, Scheithauer BW, Trastek VF, Kvols LK: Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome. Mayo Clin Proc 1990;65:1314-1321.
19. Dickstein G, DeBold CR, Gaitans D, DeCherney GS, Jackson RV, Sheldon WR Jr, Nicholson WE, Orth DN: Plasma corticotropin and Cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. J Clin Endocrinol Metab 1996;81:2934-2941.
20. Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A: A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997;82:176-181.
21. Malerbi DA, Mendonça BB, Liberman B, Toledo SPA, Corradini MCM, Cunha-Neto MB, Fragoso MCB, Wajchenberg BL: The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol 1993;39:463-472.
22. Arlt W, Dahia PLM, Callies F, Nordmeyer JP, Allolio B, Grossmann AB, Reincke M: Ectopic ACTH production by a bronchial carcinoid tumor responsive to desmopressin in vivo and in vitro. Clin Endocrinol 1997;47:623-627.
23. Nadal M: Secretory rhythm of vasopressin in healthy subjects with inversed sleep-wake cycle: Evidence for the existence of an intrinsic regulation. Eur J Endocrinol 1996;134:174-176.
24. Limper AH, Carpenter PC, Scheithauer B, Staats BA: The Cushing syndrome induced by bronchial carcinoid tumors. Ann Intern Med 1992;117:209-214.
25. Vantyghem MC, Hober C, Foissey D, Lefebvre J: Tumeurs carcinoïdes: Avancées récentes diagnostiques et thérapeutiques. Rev Fr Endocrinol Clin Nutr Metab 1995;36:439-448.
26. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler B, Loriaux DL: Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991;325:897-905.
27. Vanovski JA, Cutler GB, Doppman JL, Miller DL, Chrousos GP, Oldfield EH, Nieman LK: The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology. J Clin Endocrinol Metab 1993;77:503-509.
28. Philipponeau M, Nocaudie M, Epelbaum J, de Keyzer Y, Lalaw JD, Marchandise X, Bertagna X: Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 1994;78:20-24.
29. Lamberts SWJ, Reubi JC: A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. Editorial. J Clin Endocrinol Metab 1994;78:17-19.
30. Wajchenberg BL, Mendonca BB, Liberman B, Albergaria Pereira MA, Campos Carneiro P, Wakamatsu A, Kirschner MA: Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 1994;15:752-787.
31. Carnaille B, Nocaudie M, Pattou F, Huglo D, Deveaux M, Marchandise X, Proye C: Scintiscans and carcinoid tumors. Surgery 1994;116:1118-1122.
32. Boubaker A, Bischof Delaloye A, Gomez F, Gaillard R, Delaloye B: Comparison of I-123-MIBG and In-111-octreotide in patients with suspected neuroendocrine tumor: A prospective study. Eur J Nucl Med 1996;22:898.
33. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C: Comparison of radiolabeled octreotide and metaiodobenzylguanidine (MIBG) scintigraphy of malignant pheochromocytoma. J Nucl Med 1995;36:1-6.
34. Hoefnagel CA: MIBG and radiolabeled octreotide in neuroendocrine tumors. Q J Nucl Med 1995;39:137-139.
35. Hirano T, Otake H, Watanabe N, Oriuchi N, Zennyouji A, Fukuda T, Endo K: Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG. J Nucl Med 1995;36:2243-2245.
36. Mandigers CMPW, van Gils APG, Derksen J, van der Mey AGL, Hogendoon PCW: Carcinoid tumor of the jugulo-tympanic region. J Nucl Med 1996;37:270-272.
37. MacFarlane D, Gonin J, Wieland D, Mangner T, Froelich J, Beierwaltes W, Shapiro B: Successful and unsuccessful approaches to imaging carcinoids: Comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue. Eur J Nucl Med 1996;23:131-140.
38. Dusmet ME, McKneally MF: Pulmonary and thymic carcinoid tumors. World J Surg 1996;20:189-195.
39. Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972;64:413-417.
40. Marty-Ané CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H: Carcinoid tumors of the lung: Do atypical features require aggressive management? Ann Thorac Surg 1995;59:78-83.